We validated efficacy of SBE in repressing SHH signaling pathway to block NSCLC progression and confirmed that SBE selectively induced repression of aberrantly activated SHH signaling pathway leading to disruption of the SHH-mediated non-small cell lung carcinoma progression and metastasis via cell cycle arrest. This evidence concerns the gene SHH and non-small cell lung carcinoma.